Skip to main content

Advertisement

Log in

Short-Term Use of Injectable Contraception: An Effective Strategy for Safe Motherhood

  • Invited Mini Review
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. http://world.time.com/2013/07/19/world-population-focus-on-india-part-2-unsafe-abortions/.

  2. Singh S, Darroch JE, Ashford LS, et al. Adding it up: the costs and benefits of investing in family planning and maternal and newborn health. New York: Guttmacher Institute and United Nations Population Fund; 2009.

    Google Scholar 

  3. Liu L, Becker S, Tsui A, et al. Three methods of estimating births averted nationally by contraception. Popul Stud (Camb). 2008;62:191–210.

    Article  Google Scholar 

  4. Joshi R, Khadilkar S, Patel M. Global trends in use of long-acting reversible and permanent methods of contraception: seeking a balance. Int J Gynaecol Obstet. 2015;131(Suppl 1):S60–3.

    Article  PubMed  Google Scholar 

  5. Said S, Omar K, Koetsawang S, et al. A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1987;35:591–610.

    Article  CAS  PubMed  Google Scholar 

  6. National Collaborating Centre for Women’s and Children’s Health (UK). NICE clinical guidelines, No. 30. London: RCOG Press; 2005.

    Google Scholar 

  7. Jain J, Dutton C, Nicosia A, et al. Pharmacokinetics, ovulation suppression and return to ovulation following a lower dose subcutaneous formulation of Depo-Provera(R). Contraception. 2004;70:11–8.

    Article  CAS  PubMed  Google Scholar 

  8. Task force on long-acting agents for the regulation of fertility. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisteroneenanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report. Contraception. 1983;28:1–20.

  9. Sekadde-Kigondu C, Mwathe EG, Ruminjo JK, et al. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya. East Afr Med J. 1996;73:786–94.

    CAS  PubMed  Google Scholar 

  10. Khadilkar S, Sood A, Shivkar KS, et al. Short term use of INJ DMPA: key to successful family planning programme. Contraception and fertility control (EP9.033). BJOG Int J Obstet Gynaecol. 2016;123:170–7. doi:10.1111/1471-0528.14107.

    Article  Google Scholar 

  11. Schwallie PC, Assenzo JR. The effect of depo-medroxyprogesterone acetate on pituitary and ovarian function, and the return of fertility following its discontinuation: a review. Contraception. 1974;10:181–202.

    Article  CAS  PubMed  Google Scholar 

  12. Technical guidance/competence working group and World Health Organization. Progestin-only injectables (DMPA and NET-EN). Recommendations for updating selected practices in contraceptive use. www.reproline.jhu.edu/english/6read/6multi/tgwg/tgit__e.htmBackground%20and%20Contributors. Accessed 17 Sept 2005.

  13. WHO. Medical eligibility criteria for contraceptive use. Geneva: World Health Organization; fifth, edition 2015. http://apps.who.int/iris/bitstream/10665/181468/1/9789241549158_eng.pdf?ua=1.

  14. Mohllajee AP, Curtis KM. Progestogen-only contraceptive use in obese women. World Health Organization, division of reproductive health, centers for disease control and prevention. US Agency for International Development and National Institute of Child Health and Human Development; 2004.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suvarna Satish Khadilkar.

Additional information

Dr. Mrs. Suvarna Satish Khadilkar is an Associate Editor, and working as Consultant Gyne-Endocrinologist, Bombay Hospital Institute of Medical Sciences and Medical Research Center, Mumbai.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khadilkar, S.S. Short-Term Use of Injectable Contraception: An Effective Strategy for Safe Motherhood. J Obstet Gynecol India 68, 82–87 (2018). https://doi.org/10.1007/s13224-017-1029-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-017-1029-9

Keywords

Navigation